Sign in

CIK 0001828673

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

HCW Biologics Inc.

Sign in to watch
Ticker
HCWB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825024477
Phone
+1 954-842-2024
Business address
2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
  1. 4 Other disposition 10% owner disposed of 3,587,659 shares (other)
  2. 4/A Open-market buy Chief Financial Officer bought 10,000 shares at $4.40 ($43,979)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Chief Executive Officer bought 3,830 shares at $3.93 ($15,070)
  9. 4 Open-market buy Chief Executive Officer bought 18,500 shares at an average $3.85 ($71,190)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 3,611 shares at $4.10 ($14,821)
  12. 4 Open-market buy SVP of Business Development bought 13,458 shares at an average $4.03 ($54,226)
  13. 4/A Open-market buy SVP of Business Development bought 10,532 shares at $4.29 ($45,218)
  14. 4 Open-market buy SVP of Business Development bought 10,532 shares at $4.25 ($44,785)
  15. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.40 ($43,979)
  16. 4 Conversion 10% owner acquired 3,587,661 shares (conversion)
  17. 4 Open-market buy Director bought 125,000 shares at $8.00 ($1,000,000)
  18. 4 Open-market buy See Remarks bought 12,500 shares at $8.00 ($100,000)
  19. 4 Open-market buy SVP of Business Development bought 31,250 shares at $8.00 ($250,000)
  20. 4 Open-market buy Chief Financial Officer bought 25,000 shares at $8.00 ($200,000)

Page 5 of 6 · 109 filings